Cochlear receives FDA approval on new hearing device Kanso™
FDA
Cochlear has announced received U.S. Food and Drug Administration (FDA) approval for its newest "innovative hearing loss solution", Kanso™. Commercial availability is expected this fall in the US.
According to the press release, Kanso is the smallest, lightest off-the-ear sound processor on the market. It provides a more discreet hearing solution and delivers the same hearing experience as a behind-the-ear sound processor. The name Kanso is a Japanese word for ‘simplicity,’ and it was selected in recognition of Kanso’s all-in-one design. The Kanso Sound Processor features a single on/off button with no cables so it is easy to use. It is worn on the user’s head with nothing behind the ear, adding greater comfort for those with glasses, and it can be easily hidden under or blended within a user’s hair.
“Our recipients are at the heart of everything we do at Cochlear, and delivering Kanso to the market is in direct response to us listening to our customers,” said Tony Manna, President of Cochlear North America. “Through customer feedback, we identified the need for a new solution that provides the advanced technology and hearing performance of our latest cochlear implant sound processor, which is worn behind the ear, in an easy and discreet design with access to wireless and water accessories, all without losing the high-quality hearing experience our customers expect from our products. Kanso offers all that and much more.”
Source: Cochlear Ltd
